Miguel Ángel Macías-Islas

Author

Also Known As

M A Macías-Islas, M Macias-Islas, M. A. Macias-Islas, M. A. Macías-Islas, M.A. Macías Islas, M.A. Macías-Islas, MA Macías Islas, Miguel A Macias-Islas, Miguel A Macías-Islas, Miguel A. Macias Islas

Publications

Citations

H-Index

Concepts

All Affiliations

Universidad de Guadalajara Mexican Social Security Institute Instituto Nacional de Neurología y Neurocirugía Hospital de Especialidades University of California, Los Angeles

MÁ

About

Miguel Ángel Macías-Islas is an author at Universidad de Guadalajara specializing in medicine, neurology, and neuroimmunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	405
2	Public Health	2	2	100
3	Health Sciences	1	1	42
4	Social Sciences	1	1	20
5	Geriatrics	1	1	42

Miguel Ángel Macías-Islas

Publications

Citations

H-Index

Page 1

	Year	Citations
Efficacy of Fish Oil on Serum of TNF<i>α</i>, IL-1<i>β</i>, and IL-6 Oxidative Stress Markers in Multiple Sclerosis Treated with Interferon Beta-1b Viridiana Ramírez-Ramírez, Miguel Ángel Macías-Islas, Genaro Gabriel Ortíz, Oxidative Medicine and Cellular Longevity	2013	119
Prevalence of Migraine in Latin America Luis E. Morillo, Fernando Alarcón, Nayesca Aranaga, Headache The Journal of Head and Face Pain	2005	114
The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis Yára Dadalti Fragoso, Mike Boggild, Miguel Ángel Macías-Islas, Clinical Neurology and Neurosurgery Maternal ImmunizationNeurological DisorderMedicineDisease-modifying DrugsMaternal Health	2012	77
The A431E mutation in PSEN1 causing Familial Alzheimer’s Disease originating in Jalisco State, Mexico: an additional fifteen families Jill R. Murrell, Bernardino Ghetti, Elizabeth J. Cochran, Neurogenetics Neurodegenerative DiseasesGeriatric NeurologyAlzheimer's DiseaseAdditional Fifteen FamiliesGenetics	2006	76
Effect of melatonin administration on the PER1 and BMAL1 clock genes in patients with Parkinson’s disease Daniela L. C. Delgado-Lara, Gracia Viviana González-Enríquez, Blanca Miriam Torres-Mendoza, Biomedicine & Pharmacotherapy Sleep DisordersMelatonin AdministrationParkinson ’NeurologyCircadian Rhythm	2020	75
Oxidative stress is increased in serum from Mexican patients with relapsing-remitting multiple sclerosis. Genaro Gabriel Ortíz, Miguel Ángel Macías-Islas, Fermín Paúl Pacheco-Moisés, PubMed	2009	54
Clinical Characteristics and Patterns of Medication Use of Migraneurs in Latin America From 12 Cities in 6 Countries Luis E. Morillo, Fernando Alarcón, Nayesca Aranaga, Headache The Journal of Head and Face Pain	2005	53
Oxidative Stress is Increased in Serum from Mexican Patients with Relapsing-Remitting Multiple Sclerosis Genaro Gabriel Ortíz, Miguel Ángel Macías-Islas, Fermín Paúl Pacheco-Moisés, Disease Markers InflammationNeurodegenerative DiseasesRelapsing-remitting Multiple SclerosisNeurological DisorderMedicine	2009	47
A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial Tjalf Ziemssen, Ovidiu Băjenaru, Adriana Carrá, Journal of Neurology	2014	42
Prevalence of Cognitive Impairment and Depression among a Population Aged over 60 Years in the Metropolitan Area of Guadalajara, Mexico Genaro Gabriel Ortíz, Elva Dolores Arias‐Merino, María E. Flores-Saiffe, Current Gerontology and Geriatrics Research Geriatric PsychiatryAgingElderly PatientsMental HealthGeriatric Medicine	2012	42

Page 1